EIF4A3 and hepatocellular carcinoma: Xue et al. (2021) reported that EIF4A3 expression is upregulated in Hepatocellular Carcinoma patients and positively correlated with the worst outcomes. While a study on gastric cancer revealed that low EIF4A3 expression is associated with poor prognosis (Wang et al., 2021a).